Sandra Garcet

3.4k total citations
72 papers, 2.1k citations indexed

About

Sandra Garcet is a scholar working on Dermatology, Immunology and Physiology. According to data from OpenAlex, Sandra Garcet has authored 72 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Dermatology, 35 papers in Immunology and 21 papers in Physiology. Recurrent topics in Sandra Garcet's work include Dermatology and Skin Diseases (40 papers), Psoriasis: Treatment and Pathogenesis (31 papers) and Asthma and respiratory diseases (20 papers). Sandra Garcet is often cited by papers focused on Dermatology and Skin Diseases (40 papers), Psoriasis: Treatment and Pathogenesis (31 papers) and Asthma and respiratory diseases (20 papers). Sandra Garcet collaborates with scholars based in United States, Germany and Japan. Sandra Garcet's co-authors include James G. Krueger, Emma Guttman‐Yassky, Mary Sullivan‐Whalen, Patricia Gilleaudeau, Juana Gonzalez, Xuan Li, Judilyn Fuentes‐Duculan, Mayte Suárez‐Fariñas, Kristina Navrazhina and John W. Frew and has published in prestigious journals such as Scientific Reports, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.

In The Last Decade

Sandra Garcet

67 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Garcet United States 25 1.5k 816 636 478 291 72 2.1k
Seth Forman United States 19 1.9k 1.2× 367 0.4× 1.1k 1.7× 444 0.9× 527 1.8× 55 2.3k
Thomas Hultsch United States 22 1.6k 1.1× 413 0.5× 1.6k 2.4× 814 1.7× 283 1.0× 44 2.4k
Artemis Khatcherian United States 12 1.2k 0.8× 1.7k 2.1× 280 0.4× 507 1.1× 231 0.8× 13 2.3k
Luca Potestio Italy 25 839 0.5× 778 1.0× 127 0.2× 207 0.4× 142 0.5× 114 1.4k
Israel Coats United States 11 773 0.5× 723 0.9× 296 0.5× 297 0.6× 155 0.5× 11 1.2k
Darryl Toth Canada 14 954 0.6× 1.2k 1.5× 329 0.5× 228 0.5× 321 1.1× 33 1.7k
Katherine C. Pierson United States 13 917 0.6× 1.7k 2.1× 123 0.2× 423 0.9× 209 0.7× 14 2.2k
Masayuki Kitajima Japan 16 357 0.2× 482 0.6× 288 0.5× 350 0.7× 82 0.3× 65 1.3k
Benjamin F. Chong United States 22 565 0.4× 1.3k 1.6× 128 0.2× 98 0.2× 672 2.3× 80 2.2k
Cornelia S. Seitz Germany 18 351 0.2× 283 0.3× 264 0.4× 109 0.2× 130 0.4× 43 1.3k

Countries citing papers authored by Sandra Garcet

Since Specialization
Citations

This map shows the geographic impact of Sandra Garcet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Garcet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Garcet more than expected).

Fields of papers citing papers by Sandra Garcet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Garcet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Garcet. The network helps show where Sandra Garcet may publish in the future.

Co-authorship network of co-authors of Sandra Garcet

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Garcet. A scholar is included among the top collaborators of Sandra Garcet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Garcet. Sandra Garcet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Warren, Richard B., Anne Weiss, Jakob Felding, et al.. (2025). Orismilast, a Potent and Selective PDE4B /D Inhibitor, Reduces Protein Levels of Key Disease Driving Cytokines in the Skin of Patients With Plaque Psoriasis. Experimental Dermatology. 34(9). e70153–e70153.
2.
Krueger, James G., Sandra Garcet, Sanjay Kumar, et al.. (2024). 265 Modulation of disease-central cytokine pathways with TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, defines clinical response in patients with psoriasis. Journal of Investigative Dermatology. 144(8). S46–S46. 1 indexed citations
3.
Navrazhina, Kristina, Yael Renert‐Yuval, Saakshi Khattri, et al.. (2023). 148 Tape strips detect molecular alterations and cutaneous biomarkers in hidradenitis suppurativa skin. Journal of Investigative Dermatology. 143(11). S357–S357. 1 indexed citations
4.
Blauvelt, Andrew, David M. Pariser, Stephen K. Tyring, et al.. (2023). Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study. Journal of Dermatological Science. 109(1). 12–21. 11 indexed citations
5.
Garcet, Sandra, et al.. (2023). 371 The OX40/OX40L axis plays a key role in treg dysfunction in atopic dermatitis. Journal of Investigative Dermatology. 143(5). S64–S64. 1 indexed citations
6.
Miura, Shunsuke, Yohei Ichimura, Uri Sela, et al.. (2023). Staphylococcus Aureus and Streptococcus Pyogenes Induce Psoriasis-Related Transcriptomes Augmented by IL-17A and TNF-α. Journal of Investigative Dermatology. 143(8). 1613–1617.e5. 9 indexed citations
7.
Campbell, Kim, Katherine Li, Feifei Yang, et al.. (2023). Guselkumab More Effectively Neutralizes Psoriasis-Associated Histologic, Transcriptomic, and Clinical Measures than Ustekinumab. ImmunoHorizons. 7(4). 273–285. 7 indexed citations
8.
Wang, Claire Q., Sokol Haxhinasto, Sandra Garcet, et al.. (2022). Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis. Journal of Investigative Dermatology. 143(1). 87–97.e14. 12 indexed citations
9.
Renert‐Yuval, Yael, Joel Corrêa da Rosa, Sandra Garcet, et al.. (2022). Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes. British Journal of Dermatology. 187(4). 539–547. 11 indexed citations
10.
Renert‐Yuval, Yael, Ana B. Pavel, Ester Del Duca, et al.. (2022). Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata. Allergy. 78(4). 1047–1059. 34 indexed citations
11.
Miura, Shunsuke, Sandra Garcet, Xuan Li, et al.. (2022). Cathelicidin Antimicrobial Peptide LL37 Induces Toll-Like Receptor 8 and Amplifies IL-36γ and IL-17C in Human Keratinocytes. Journal of Investigative Dermatology. 143(5). 832–841.e4. 21 indexed citations
12.
Guttman‐Yassky, Emma, Yael Renert‐Yuval, Margot Chima, et al.. (2021). Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patients. Allergy. 77(3). 897–906. 88 indexed citations
13.
Miura, Shunsuke, Sandra Garcet, Juana Gonzalez, et al.. (2021). IL-36 and IL-17A Cooperatively Induce a Psoriasis-Like Gene Expression Response in Human Keratinocytes. Journal of Investigative Dermatology. 141(8). 2086–2090. 14 indexed citations
14.
Page, Karen, Mayte Suárez‐Fariñas, Maria Suprun, et al.. (2020). Molecular and Cellular Responses to the TYK2/JAK1 Inhibitor PF-06700841 Reveal Reduction of Skin Inflammation in Plaque Psoriasis. Journal of Investigative Dermatology. 140(8). 1546–1555.e4. 42 indexed citations
15.
Frew, John W., Mayte Suárez‐Fariñas, Sandra Garcet, et al.. (2020). The erythema Q‐score, an imaging biomarker for redness in skin inflammation. Experimental Dermatology. 30(3). 377–383. 12 indexed citations
16.
Muñoz‐Forner, Elena, Leopoldo Forner, Sandra Garcet, Francisco Javier Rodríguez‐Lozano, & Carmen Llena. (2019). Canal shaping with a reciprocating system is easy to learn. International Endodontic Journal. 52(8). 1244–1249. 8 indexed citations
17.
Mashiko, Shunya, Rebecca M. Edelmayer, Yingtao Bi, et al.. (2019). Persistence of Inflammatory Phenotype in Residual Psoriatic Plaques in Patients on Effective Biologic Therapy. Journal of Investigative Dermatology. 140(5). 1015–1025.e4. 13 indexed citations
18.
Brunner, Patrick M., Ryan Emerson, Christopher M. Tipton, et al.. (2017). Nonlesional atopic dermatitis skin shares similar T‐cell clones with lesional tissues. Allergy. 72(12). 2017–2025. 65 indexed citations
19.
Khattri, Saakshi, Patrick M. Brunner, Sandra Garcet, et al.. (2016). Efficacy and safety of ustekinumab treatment in adults with moderate‐to‐severe atopic dermatitis. Experimental Dermatology. 26(1). 28–35. 170 indexed citations
20.
Brunner, Patrick M., Saakshi Khattri, Sandra Garcet, et al.. (2016). A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis. Journal of Allergy and Clinical Immunology. 138(1). 169–178. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seth Forman Breakdown of academic impact, for papers by Thomas Hultsch Breakdown of academic impact, for papers by Artemis Khatcherian Breakdown of academic impact, for papers by Luca Potestio Breakdown of academic impact, for papers by Israel Coats Breakdown of academic impact, for papers by Darryl Toth Breakdown of academic impact, for papers by Katherine C. Pierson Breakdown of academic impact, for papers by Masayuki Kitajima Breakdown of academic impact, for papers by Benjamin F. Chong Breakdown of academic impact, for papers by Cornelia S. Seitz
Rankless by CCL
2026